FDA accepted NDA for zidesamtinib for the treatment of TKI pre-treated patients with advanced ROS1-positive NSCLC; PDUFA target action date of September ...
Two effective manipulatives that can be used to support fractions and base 10 learning are base 10 blocks and Cuisenaire rods ...